Lazard Asset Management LLC Sells 129,220 Shares of Mirion Technologies, Inc. (NYSE:MIR)

Lazard Asset Management LLC lowered its position in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 31.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 278,817 shares of the company's stock after selling 129,220 shares during the period. Lazard Asset Management LLC owned approximately 0.12% of Mirion Technologies worth $4,865,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC grew its position in Mirion Technologies by 1,532.2% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 520,692 shares of the company's stock worth $8,810,000 after purchasing an additional 488,790 shares during the period. Exchange Traded Concepts LLC grew its position in Mirion Technologies by 291.4% in the 4th quarter. Exchange Traded Concepts LLC now owns 88,830 shares of the company's stock worth $1,550,000 after purchasing an additional 66,132 shares during the period. Artemis Investment Management LLP bought a new stake in Mirion Technologies in the 4th quarter worth approximately $38,155,000. Barclays PLC grew its position in Mirion Technologies by 325.0% in the 3rd quarter. Barclays PLC now owns 307,680 shares of the company's stock worth $3,405,000 after purchasing an additional 235,288 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new stake in Mirion Technologies in the 4th quarter worth approximately $394,000. Institutional investors own 78.51% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Robert W. Baird cut their target price on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, April 4th. Citigroup cut their target price on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Finally, B. Riley cut their target price on shares of Mirion Technologies from $19.00 to $17.00 and set a "buy" rating for the company in a research report on Wednesday, April 16th. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $18.75.

Mirion Technologies Stock Performance

Shares of Mirion Technologies stock traded up $0.95 on Wednesday, hitting $18.39. 5,781,267 shares of the company's stock were exchanged, compared to its average volume of 1,734,476. The company has a 50-day simple moving average of $14.98 and a 200-day simple moving average of $15.87. The stock has a market capitalization of $4.27 billion, a PE ratio of -96.83 and a beta of 0.74. Mirion Technologies, Inc. has a 1 year low of $9.11 and a 1 year high of $18.88. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.55 and a current ratio of 2.16.

Mirion Technologies (NYSE:MIR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. The business had revenue of $202.00 million for the quarter, compared to analysts' expectations of $199.34 million. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The company's revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.06 EPS. As a group, equities analysts anticipate that Mirion Technologies, Inc. will post 0.39 EPS for the current year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.